Navaid Asad, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 4 carriers
- Offices
- 4
Offices
4 locations · County of Santa Clara · Sanford Medical Center
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Asad’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C55215 · Current
Licensed to practise in California · since 2012 · expires 2027-10-31 · Russian State Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$28,127
Medicare paid this office $28,127 for 346 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $13,398 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,019 | $112 |
| Short return visit (20+ min) | 41 | $4,042 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,254 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $398 | $19 |
See all 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $13,398 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,019 | $112 |
| Short return visit (20+ min) | 41 | $4,042 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,254 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $398 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $311 | $12 |
| Ultrasound of heart, follow-up | 12 | $287 | $22 |
Who their Medicare patients are
346 Original Medicare patients in 2024. Average age 75 · Under 65 14% · 85 and older 23% · Women 50% · Also on Medicaid 72% · Health risk score 2.65. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 56% · Coronary heart disease 49% · Heart failure 48% · Chronic kidney disease 41% · Atrial fibrillation 36% · Depression 33% · COPD 26% · Dementia 25% · Stroke 23% · Cancer 14%.
The office billed $352,173, Medicare allowed $37,848 and paid $28,127; for 453 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 346 | 453 | 75 | 2.65 | $352,173 | $28,127 |
| 2023 | 268 | 364 | 75 | 2.57 | $249,049 | $22,574 |
| 2022 | 61 | 109 | 69 | 1.91 | $32,114 | $6,358 |
| 2021 | 58 | 102 | 69 | 1.65 | $36,137 | $8,202 |
| 2020 | 120 | 228 | 78 | 2.09 | $63,600 | $21,177 |
| 2019 | 286 | 1,850 | 79 | 1.83 | $327,406 | $150,464 |
| 2018 | 273 | 2,062 | 77 | 2.54 | $196,687 | $102,445 |
| 2017 | 416 | 1,982 | 75 | 1.74 | $419,959 | $119,281 |
| 2016 | 488 | 2,678 | 74 | 1.45 | $748,162 | $201,520 |
| 2015 | 414 | 2,015 | 72 | 1.48 | $541,542 | $152,562 |
| 2014 | 402 | 2,132 | 74 | 1.43 | $559,509 | $163,407 |
| 2013 | 397 | 1,030 | 77 | 1.78 | $226,883 | $72,693 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $9,501 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,557 | $117 |
| Short return visit (20+ min) | 36 | $4,000 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 49 | $395 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $212 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $139 | $13 |
2022: 3 services
| Return visit (30+ min) | 32 | $2,485 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $2,100 | $117 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $196 | $7 |
2021: 3 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $2,986 | $136 |
| Return visit (30+ min) | 30 | $2,477 | $65 |
| Long return visit (40+ min) | 17 | $1,498 | $88 |
2020: 4 services
| Long return visit (40+ min) | 40 | $7,448 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $2,416 | $67 |
| Return visit (30+ min) | 29 | $2,283 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $2,119 | $141 |
2019: 20 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 20 | $30,784 | $1,539 |
| Return visit (30+ min) | 77 | $20,442 | $99 |
| Long return visit (40+ min) | 67 | $16,110 | $134 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 81 | $15,011 | $185 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 20 | $9,825 | $351 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 137 | $9,009 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $8,552 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $6,790 | $485 |
| New patient visit (60+ min) | 40 | $6,770 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,037 | $172 |
| Critical care, first 30-74 minutes | 12 | $4,294 | $195 |
| New patient visit (45+ min) | 22 | $2,867 | $130 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 13 | $2,481 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,225 | $65 |
| Injection, regadenoson, 0.1 mg | 12 | $2,220 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $2,123 | $82 |
| Short return visit (20+ min) | 12 | $773 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $677 | $16 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 20 | $405 | None |
| Infusion, normal saline solution, 250 cc | 18 | $50 | None |
2018: 14 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 20 | $30,553 | $1,528 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 19 | $15,359 | $404 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $12,005 | $65 |
| Return visit (30+ min) | 41 | $8,769 | $99 |
| Long return visit (40+ min) | 44 | $7,168 | $124 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $6,616 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,123 | $180 |
| New patient visit (60+ min) | 30 | $5,259 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,483 | $93 |
| Short return visit (20+ min) | 14 | $1,374 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $1,373 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $931 | $85 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 20 | $779 | None |
| Infusion, normal saline solution, 250 cc | 22 | $87 | None |
2017: 14 services
| Return visit (30+ min) | 219 | $31,015 | $71 |
| Long return visit (40+ min) | 187 | $30,665 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 175 | $8,681 | $49 |
| New patient visit (60+ min) | 47 | $5,824 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,006 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $3,674 | $216 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $3,603 | $57 |
| Short return visit (20+ min) | 36 | $2,914 | $49 |
| New patient visit (45+ min) | 14 | $1,422 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,401 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 61 | $1,096 | $18 |
| Programming of dual lead pacemaker system | 20 | $972 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $762 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 60 | $725 | $12 |
2016: 13 services
| Return visit (30+ min) | 265 | $66,793 | $79 |
| Long return visit (40+ min) | 247 | $57,324 | $110 |
| Short return visit (20+ min) | 122 | $17,032 | $55 |
| New patient visit (60+ min) | 107 | $14,180 | $133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 273 | $13,698 | $47 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 124 | $7,740 | $62 |
| Critical care, first 30-74 minutes | 17 | $6,817 | $170 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,448 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 133 | $2,395 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $1,779 | $71 |
| New patient visit (45+ min) | 15 | $1,717 | $114 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 133 | $1,567 | $12 |
| Programming of dual lead pacemaker system | 15 | $846 | $40 |
2015: 15 services
| Return visit (30+ min) | 257 | $60,574 | $79 |
| Long return visit (40+ min) | 155 | $28,022 | $111 |
| New patient visit (60+ min) | 109 | $16,735 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $12,695 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $9,108 | $163 |
| Short return visit (20+ min) | 77 | $7,050 | $53 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 89 | $5,362 | $60 |
| Critical care, first 30-74 minutes | 11 | $2,710 | $181 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 102 | $1,816 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,441 | $76 |
| New patient visit (45+ min) | 15 | $1,354 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 102 | $1,184 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $1,148 | $72 |
| Programming of dual lead pacemaker system | 11 | $680 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $212 | $13 |
2014: 15 services
| Long return visit (40+ min) | 214 | $43,835 | $110 |
| Return visit (30+ min) | 211 | $38,968 | $80 |
| New patient visit (60+ min) | 143 | $21,389 | $150 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $15,075 | $50 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 146 | $9,040 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,064 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $6,373 | $84 |
| Critical care, first 30-74 minutes | 19 | $6,153 | $176 |
| New patient visit (45+ min) | 32 | $3,487 | $109 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 144 | $2,518 | $17 |
| Short return visit (20+ min) | 30 | $1,966 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 144 | $1,668 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,065 | $71 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $467 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $344 | $14 |
2013: 13 services
| Return visit (30+ min) | 114 | $21,553 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $8,420 | $50 |
| New patient visit (45+ min) | 67 | $7,288 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,222 | $154 |
| New patient visit (60+ min) | 44 | $7,000 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,378 | $81 |
| Short return visit (20+ min) | 126 | $4,536 | $32 |
| Long return visit (40+ min) | 21 | $3,019 | $116 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $1,915 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 57 | $657 | $12 |
| Programming of dual lead pacemaker system | 13 | $525 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $382 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $336 | $21 |
Medicaid work
$11,550 in 2024
Medicaid paid $11,550 for 1,102 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 464 | $8,203 |
| Short return visit (20+ min) | 192 | $2,570 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 26 | $545 |
| CARDIOVASCULAR STRESS TEST | 30 | $135 |
| CARDIOVASCULAR STRESS TEST | 28 | $97 |
| Medication list documented in medical record (COA) | 103 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 94 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 59 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 106 | $0 |
| 2024 | 1,102 | 9 | 63 | $11,550 |
| 2023 | 1,186 | 5 | 189 | $11,385 |
| 2022 | 155 | 1 | 141 | $501 |
| 2020 | 85 | 1 | 35 | $440 |
| 2019 | 122 | 1 | 108 | $773 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 367 | $7,218 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 694 | $3,241 |
| Short return visit (20+ min) | 97 | $726 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $200 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 155 | $501 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 85 | $440 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 122 | $773 |
Drugs they prescribed that Part D paid
$67,673
Pharmacies billed $67,673 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 466) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
413 generic and 53 brand-name prescriptions · $67,673 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 28 | $37,211 | $1,329 |
| Xarelto | 16 | $19,295 | $1,206 |
| Bisoprolol | 34 | $1,455 | $43 |
| Losartan | 77 | $481 | $6 |
| Torsemide | 22 | $427 | $19 |
See all 12 drugs
| Eliquis | 28 | $37,211 | $1,329 |
| Xarelto | 16 | $19,295 | $1,206 |
| Bisoprolol | 34 | $1,455 | $43 |
| Losartan | 77 | $481 | $6 |
| Torsemide | 22 | $427 | $19 |
| Clopidogrel | 21 | $228 | $11 |
| Atorvastatin | 32 | $215 | $7 |
| Carvedilol | 22 | $209 | $10 |
| Nitroglycerin | 18 | $196 | $11 |
| Amlodipine Besylate | 56 | $184 | $3 |
| Spironolactone | 17 | $179 | $11 |
| Lisinopril | 14 | $112 | $8 |
Year by year
| 2024 | 466 | 102 | 0% (0) | 11% | $67,673 |
| 2023 | 1,551 | 478 | 0% (0) | 11% | $156,810 |
| 2022 | 4,127 | 719 | 0% (0) | 16% | $486,473 |
| 2021 | 3,634 | 668 | 0% (0) | 17% | $436,265 |
| 2020 | 1,517 | 388 | 0% (0) | 18% | $192,655 |
| 2019 | 731 | 108 | 0% (0) | 20% | $119,187 |
| 2018 | 526 | 105 | 0% (0) | 17% | $75,505 |
| 2017 | 1,393 | 242 | 0% (0) | 17% | $150,929 |
| 2016 | 1,751 | 267 | 0% (0) | 20% | $183,012 |
| 2015 | 1,849 | 241 | 0% (0) | 21% | $132,492 |
| 2014 | 2,098 | 228 | 0% (0) | 25% | $120,200 |
| 2013 | 1,649 | 223 | None | 23% | $83,857 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Xarelto | 34 | $41,367 | $1,217 |
| Eliquis | 30 | $38,254 | $1,275 |
| Entresto | 13 | $10,149 | $781 |
| Pradaxa | 32 | $9,531 | $298 |
| Bisoprolol | 259 | $7,591 | $29 |
| Losartan | 216 | $3,183 | $15 |
| Diltiazem 24hr Er (Cd) | 71 | $2,093 | $29 |
| Amlodipine Besylate | 140 | $1,794 | $13 |
| Torsemide | 66 | $1,408 | $21 |
| Amiodarone | 30 | $1,239 | $41 |
| Nitroglycerin | 74 | $1,214 | $16 |
| Atorvastatin | 76 | $1,085 | $14 |
| Metoprolol | 46 | $1,023 | $22 |
| Rosuvastatin | 34 | $575 | $17 |
| Spironolactone | 48 | $574 | $12 |
| Clopidogrel | 33 | $573 | $17 |
| Carvedilol | 30 | $540 | $18 |
| Lisinopril | 46 | $531 | $12 |
| Flecainide Acetate | 12 | $499 | $42 |
| Metoprolol | 43 | $413 | $10 |
| Hydralazine | 14 | $390 | $28 |
| Isosorbide Mononitrate Er | 25 | $329 | $13 |
| Digoxin | 11 | $301 | $27 |
| Chlorthalidone | 17 | $263 | $15 |
| Ezetimibe | 21 | $227 | $11 |
| Furosemide | 14 | $161 | $12 |
2022: 39 drugs
| Multaq | 63 | $113,843 | $1,807 |
| Eliquis | 60 | $87,231 | $1,454 |
| Pradaxa | 173 | $84,338 | $488 |
| Xarelto | 61 | $67,984 | $1,114 |
| Bisoprolol | 731 | $28,087 | $38 |
| Entresto | 22 | $21,634 | $983 |
| Diltiazem 24hr Er (Cd) | 218 | $7,030 | $32 |
| Torsemide | 214 | $4,849 | $23 |
| Losartan | 383 | $4,400 | $11 |
| Amlodipine Besylate | 323 | $3,765 | $12 |
| Propafenone Hcl Er | 14 | $3,699 | $264 |
| Metoprolol | 158 | $3,071 | $19 |
| Amiodarone | 72 | $2,847 | $40 |
| Nitroglycerin | 237 | $2,818 | $12 |
| Flecainide Acetate | 57 | $2,600 | $46 |
| Atorvastatin | 156 | $2,080 | $13 |
| Rosuvastatin | 116 | $1,978 | $17 |
| Clopidogrel | 97 | $1,846 | $19 |
| Lisinopril | 143 | $1,607 | $11 |
| Spironolactone | 95 | $999 | $11 |
| Digoxin | 42 | $984 | $23 |
| Metoprolol | 99 | $933 | $9 |
| Dofetilide | 11 | $890 | $81 |
| Carvedilol | 79 | $867 | $11 |
| Isosorbide Mononitrate Er | 60 | $784 | $13 |
| Potassium Chloride | 23 | $729 | $32 |
| Ezetimibe | 33 | $665 | $20 |
| Nifedipine Er | 12 | $633 | $53 |
| Sotalol | 23 | $599 | $26 |
| Furosemide | 39 | $426 | $11 |
| Chlorthalidone | 23 | $393 | $17 |
| Hydralazine | 18 | $340 | $19 |
| Warfarin | 27 | $336 | $12 |
| Clonidine | 11 | $335 | $30 |
| Levothyroxine | 13 | $289 | $22 |
| Hydrochlorothiazide | 25 | $275 | $11 |
| Atenolol | 25 | $271 | $11 |
| Metolazone | 11 | $258 | $23 |
| Diltiazem | 21 | $239 | $11 |
2021: 39 drugs
| Pradaxa | 156 | $93,922 | $602 |
| Multaq | 47 | $86,723 | $1,845 |
| Eliquis | 67 | $76,076 | $1,135 |
| Xarelto | 52 | $52,024 | $1,000 |
| Bisoprolol | 687 | $25,864 | $38 |
| Entresto | 16 | $21,772 | $1,361 |
| Bystolic | 11 | $7,908 | $719 |
| Diltiazem 24hr Er (Xr) | 120 | $6,025 | $50 |
| Torsemide | 241 | $5,713 | $24 |
| Diltiazem 24hr Er (Cd) | 31 | $4,331 | $140 |
| Dofetilide | 25 | $3,926 | $157 |
| Propafenone Hcl Er | 19 | $3,845 | $202 |
| Amiodarone | 79 | $3,689 | $47 |
| Metoprolol | 153 | $3,636 | $24 |
| Nitroglycerin | 239 | $3,612 | $15 |
| Amlodipine Besylate | 282 | $3,098 | $11 |
| Losartan | 266 | $3,005 | $11 |
| Flecainide Acetate | 46 | $2,297 | $50 |
| Rosuvastatin | 135 | $2,278 | $17 |
| Dilt-Xr | 35 | $1,744 | $50 |
| Atorvastatin | 107 | $1,331 | $12 |
| Lisinopril | 94 | $1,057 | $11 |
| Digoxin | 40 | $1,014 | $25 |
| Clopidogrel | 52 | $998 | $19 |
| Spironolactone | 86 | $982 | $11 |
| Chlorthalidone | 31 | $892 | $29 |
| Metoprolol | 70 | $696 | $10 |
| Carvedilol | 69 | $695 | $10 |
| Furosemide | 43 | $568 | $13 |
| Bumetanide | 11 | $558 | $51 |
| K-Tab Er | 22 | $553 | $25 |
| Isosorbide Mononitrate Er | 39 | $459 | $12 |
| Warfarin | 29 | $365 | $13 |
| Metolazone | 15 | $269 | $18 |
| Levothyroxine | 12 | $267 | $22 |
| Atenolol | 22 | $237 | $11 |
| Diltiazem | 15 | $176 | $12 |
| Hydralazine | 16 | $174 | $11 |
| Hydrochlorothiazide | 15 | $145 | $10 |
2020: 31 drugs
| Eliquis | 80 | $78,086 | $976 |
| Xarelto | 24 | $24,129 | $1,005 |
| Pradaxa | 60 | $23,250 | $388 |
| Bisoprolol | 293 | $10,410 | $36 |
| Brilinta | 14 | $7,435 | $531 |
| Bystolic | 12 | $3,057 | $255 |
| Bumetanide | 60 | $2,286 | $38 |
| Amlodipine Besylate | 181 | $1,355 | $7 |
| Metoprolol | 52 | $1,298 | $25 |
| Dilt-Xr | 21 | $1,296 | $62 |
| Torsemide | 69 | $1,267 | $18 |
| Amiodarone | 16 | $862 | $54 |
| Diltiazem 24hr Er (Cd) | 13 | $810 | $62 |
| Rosuvastatin | 32 | $697 | $22 |
| Hydralazine | 26 | $683 | $26 |
| Losartan | 59 | $679 | $12 |
| Atorvastatin | 55 | $609 | $11 |
| Carvedilol | 49 | $503 | $10 |
| Nitroglycerin | 24 | $450 | $19 |
| Lisinopril | 41 | $380 | $9 |
| Chlorthalidone | 11 | $371 | $34 |
| Clopidogrel | 12 | $345 | $29 |
| Potassium Chloride | 19 | $340 | $18 |
| Levothyroxine | 18 | $296 | $16 |
| Spironolactone | 22 | $268 | $12 |
| Benazepril | 23 | $254 | $11 |
| Pravastatin | 12 | $234 | $20 |
| Isosorbide Mononitrate Er | 19 | $192 | $10 |
| Furosemide | 18 | $174 | $10 |
| Metoprolol | 16 | $156 | $10 |
| Famotidine | 14 | $97 | $7 |
2019: 16 drugs
| Eliquis | 79 | $79,924 | $1,012 |
| Xarelto | 14 | $13,870 | $991 |
| Bisoprolol | 103 | $3,987 | $39 |
| Bumetanide | 48 | $2,494 | $52 |
| Rosuvastatin | 14 | $1,536 | $110 |
| Metoprolol | 20 | $834 | $42 |
| Amlodipine Besylate | 97 | $832 | $9 |
| Atorvastatin | 48 | $652 | $14 |
| Carvedilol | 22 | $471 | $21 |
| Losartan | 27 | $369 | $14 |
| Clopidogrel | 15 | $327 | $22 |
| Nitroglycerin | 14 | $310 | $22 |
| Spironolactone | 24 | $254 | $11 |
| Lisinopril | 18 | $170 | $9 |
| Benazepril | 11 | $161 | $15 |
| Azithromycin | 13 | $91 | $7 |
2018: 14 drugs
| Eliquis | 49 | $40,384 | $824 |
| Xarelto | 12 | $8,704 | $725 |
| Bisoprolol | 64 | $2,246 | $35 |
| Bumetanide | 24 | $1,339 | $56 |
| Atorvastatin | 31 | $465 | $15 |
| Metoprolol | 14 | $464 | $33 |
| Losartan | 40 | $436 | $11 |
| Diltiazem 24hr Er (Cd) | 11 | $435 | $40 |
| Amlodipine Besylate | 60 | $409 | $7 |
| Nitroglycerin | 13 | $268 | $21 |
| Spironolactone | 28 | $237 | $8 |
| Carvedilol | 19 | $136 | $7 |
| Benazepril | 15 | $129 | $9 |
| Lisinopril | 13 | $83 | $6 |
2017: 28 drugs
| Eliquis | 60 | $41,696 | $695 |
| Xarelto | 48 | $40,290 | $839 |
| Multaq | 15 | $23,045 | $1,536 |
| Bisoprolol | 180 | $7,074 | $39 |
| Digoxin | 36 | $2,241 | $62 |
| Atorvastatin | 104 | $2,014 | $19 |
| Valsartan | 20 | $1,618 | $81 |
| Bumetanide | 35 | $1,491 | $43 |
| Rosuvastatin | 13 | $1,446 | $111 |
| Losartan | 138 | $1,432 | $10 |
| Amlodipine Besylate | 168 | $1,427 | $8 |
| Levothyroxine | 37 | $1,227 | $33 |
| Diltiazem 24hr Er | 36 | $1,093 | $30 |
| Metoprolol | 29 | $903 | $31 |
| Carvedilol | 75 | $705 | $9 |
| Isosorbide Mononitrate Er | 24 | $703 | $29 |
| Pravastatin | 21 | $555 | $26 |
| Prazosin | 12 | $459 | $38 |
| Cartia Xt | 12 | $455 | $38 |
| Amiodarone | 13 | $443 | $34 |
| Sotalol | 13 | $402 | $31 |
| Lisinopril | 47 | $336 | $7 |
| Clopidogrel | 15 | $309 | $21 |
| Spironolactone | 32 | $266 | $8 |
| Atenolol | 12 | $163 | $14 |
| Azithromycin | 25 | $144 | $6 |
| Benazepril | 17 | $142 | $8 |
| Furosemide | 11 | $33 | $3 |
2016: 35 drugs
| Xarelto | 65 | $46,839 | $721 |
| Eliquis | 73 | $46,573 | $638 |
| Multaq | 25 | $25,789 | $1,032 |
| Bisoprolol | 170 | $5,738 | $34 |
| Benicar | 11 | $3,003 | $273 |
| Atorvastatin | 123 | $2,749 | $22 |
| Amiodarone | 17 | $2,721 | $160 |
| Amlodipine Besylate | 264 | $2,613 | $10 |
| Bystolic | 22 | $2,547 | $116 |
| Valsartan | 25 | $2,277 | $91 |
| Levothyroxine | 67 | $2,022 | $30 |
| Losartan | 138 | $1,578 | $11 |
| Diltiazem 24hr Er | 21 | $1,571 | $75 |
| Digoxin | 24 | $1,320 | $55 |
| Bumetanide | 43 | $1,118 | $26 |
| Dilt-Xr | 11 | $838 | $76 |
| Metoprolol | 24 | $797 | $33 |
| Carvedilol | 93 | $781 | $8 |
| Chlorthalidone | 15 | $764 | $51 |
| Isosorbide Mononitrate Er | 30 | $758 | $25 |
| Pravastatin | 25 | $701 | $28 |
| Nitrostat | 13 | $581 | $45 |
| Cartia Xt | 14 | $572 | $41 |
| Prazosin | 12 | $556 | $46 |
| Lisinopril | 64 | $548 | $9 |
| Clopidogrel | 23 | $534 | $23 |
| Taztia Xt | 21 | $399 | $19 |
| Spironolactone | 30 | $355 | $12 |
| Sotalol | 20 | $349 | $17 |
| Diltiazem 24hr Cd | 16 | $236 | $15 |
| Azithromycin | 33 | $196 | $6 |
| Metoprolol | 13 | $140 | $11 |
| Torsemide | 11 | $138 | $13 |
| Omeprazole | 11 | $96 | $9 |
| Furosemide | 16 | $88 | $5 |
2015: 35 drugs
| Xarelto | 80 | $49,617 | $620 |
| Multaq | 34 | $23,897 | $703 |
| Crestor | 17 | $8,033 | $473 |
| Ranexa | 11 | $5,022 | $457 |
| Bisoprolol | 147 | $3,923 | $27 |
| Valsartan | 20 | $3,119 | $156 |
| Levothyroxine | 111 | $2,524 | $23 |
| Bystolic | 25 | $2,447 | $98 |
| Amiodarone | 12 | $2,384 | $199 |
| Atorvastatin | 131 | $2,377 | $18 |
| Amlodipine Besylate | 290 | $2,298 | $8 |
| Losartan | 170 | $1,366 | $8 |
| Carvedilol | 166 | $1,110 | $7 |
| Bumetanide | 34 | $984 | $29 |
| Digoxin | 16 | $971 | $61 |
| Cartia Xt | 26 | $898 | $35 |
| Metoprolol | 24 | $858 | $36 |
| Diltiazem 24hr Cd | 20 | $845 | $42 |
| Diltiazem 24hr Er | 22 | $827 | $38 |
| Potassium Chloride | 15 | $761 | $51 |
| Digox | 13 | $748 | $58 |
| Prazosin | 19 | $580 | $31 |
| Propafenone | 19 | $549 | $29 |
| Diltiazem | 20 | $507 | $25 |
| Isosorbide Mononitrate Er | 27 | $465 | $17 |
| Lisinopril | 55 | $432 | $8 |
| Hydralazine | 26 | $414 | $16 |
| Pravastatin | 15 | $285 | $19 |
| Clonidine | 27 | $250 | $9 |
| Clopidogrel | 14 | $247 | $18 |
| Sotalol | 19 | $215 | $11 |
| Spironolactone | 28 | $198 | $7 |
| Metoprolol | 18 | $114 | $6 |
| Azithromycin | 16 | $100 | $6 |
| Simvastatin | 14 | $83 | $6 |
2014: 40 drugs
| Xarelto | 103 | $44,847 | $435 |
| Diovan | 27 | $10,294 | $381 |
| Multaq | 23 | $8,495 | $369 |
| Ranexa | 11 | $4,779 | $434 |
| Bisoprolol | 159 | $4,126 | $26 |
| Diltiazem 24hr Er | 24 | $3,564 | $149 |
| Crestor | 22 | $3,445 | $157 |
| Effient | 11 | $2,821 | $256 |
| Benicar | 14 | $2,799 | $200 |
| Bystolic | 29 | $2,285 | $79 |
| Atorvastatin | 204 | $2,273 | $11 |
| Amlodipine Besylate | 274 | $2,180 | $8 |
| Metoprolol | 55 | $2,130 | $39 |
| Losartan | 176 | $1,552 | $9 |
| Carvedilol | 163 | $1,498 | $9 |
| Digox | 42 | $1,465 | $35 |
| Levothyroxine | 77 | $1,418 | $18 |
| Bumetanide | 54 | $1,204 | $22 |
| Digoxin | 28 | $1,091 | $39 |
| Amiodarone | 14 | $1,074 | $77 |
| Potassium Chloride | 26 | $787 | $30 |
| Clopidogrel | 25 | $726 | $29 |
| Isosorbide Mononitrate Er | 33 | $644 | $20 |
| Diltiazem Er | 17 | $532 | $31 |
| Lisinopril | 104 | $517 | $5 |
| Metolazone | 17 | $369 | $22 |
| Pravastatin | 17 | $333 | $20 |
| Cartia Xt | 12 | $332 | $28 |
| Diltiazem 24hr Cd | 17 | $282 | $17 |
| Sotalol | 19 | $280 | $15 |
| Spironolactone | 37 | $269 | $7 |
| Torsemide | 13 | $262 | $20 |
| Hydrochlorothiazide | 18 | $211 | $12 |
| Diltiazem | 15 | $186 | $12 |
| Metoprolol | 21 | $149 | $7 |
| Clonidine | 15 | $138 | $9 |
| Benazepril | 13 | $133 | $10 |
| Omeprazole | 16 | $131 | $8 |
| Simvastatin | 13 | $82 | $6 |
| Allopurinol | 12 | $44 | $4 |
2013: 32 drugs
| Xarelto | 91 | $27,881 | $306 |
| Multaq | 23 | $7,391 | $321 |
| Ranexa | 16 | $5,678 | $355 |
| Bisoprolol | 173 | $4,409 | $25 |
| Metoprolol | 120 | $3,731 | $31 |
| Effient | 16 | $3,631 | $227 |
| Atorvastatin | 132 | $3,039 | $23 |
| Clonidine | 12 | $2,432 | $203 |
| Benicar | 12 | $1,741 | $145 |
| Amlodipine Besylate | 226 | $1,729 | $8 |
| Losartan | 122 | $1,628 | $13 |
| Potassium Chloride | 20 | $976 | $49 |
| Carvedilol | 73 | $888 | $12 |
| Diltiazem Er | 20 | $609 | $30 |
| Isosorbide Mononitrate Er | 33 | $547 | $17 |
| Diltiazem 24hr Cd | 22 | $532 | $24 |
| Bumetanide | 42 | $510 | $12 |
| Cilostazol | 11 | $484 | $44 |
| Levothyroxine | 55 | $466 | $8 |
| Sotalol | 14 | $355 | $25 |
| Lisinopril | 42 | $235 | $6 |
| Spironolactone | 25 | $233 | $9 |
| Pravastatin | 16 | $215 | $13 |
| Nitrostat | 12 | $207 | $17 |
| Simvastatin | 21 | $204 | $10 |
| Digox | 22 | $177 | $8 |
| Warfarin | 11 | $163 | $15 |
| Amiodarone | 19 | $109 | $6 |
| Torsemide | 11 | $109 | $10 |
| Terazosin | 11 | $105 | $10 |
| Atenolol | 13 | $46 | $4 |
| Allopurinol | 11 | $40 | $4 |
Money from drug and device companies
$174 in 2020
| 2020 | 7 | 8 | None | $174 |
| 2019 | 12 | 31 | None | $699 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $40 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $31 | 1 payment
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $26 | 1 payment
|
| Pfizer | Chantix | $23 | 1 payment
|
| Amarin Pharma | Vascepa | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $19 | 1 payment
|
See all 8 published payments
| Bardy Diagnostics | Meals · 2020-06-24 | Carnation Ambulatory Monitor | $31 |
| Janssen Pharmaceuticals | Meals · 2020-03-11 | Xarelto | $20 |
| Novartis Pharmaceuticals | Meals · 2020-03-10 | Entresto | $15 |
| Amarin Pharma | Meals · 2020-03-03 | Vascepa | $20 |
| Abbott Laboratories | Meals · 2020-02-11 | Heartmate 3 Left Ventricular Dev | $26 |
| Janssen Pharmaceuticals | Meals · 2020-02-05 | Xarelto | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2020-02-03 | Brilinta | $19 |
| Pfizer | Meals · 2020-01-08 | Chantix | $23 |
See earlier years (2019)
2019: $699
| Janssen Pharmaceuticals | Xarelto | $198 | 10 payments
|
| Pfizer | Vyndaqel | $120 | 8 payments
|
| Medtronic Vascular | Azure | $115 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $42 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $40 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $40 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $29 | 2 payments
|
| Amgen | Repatha | $28 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $22 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $21 | 1 payment
|
| Relypsa | Veltassa | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104807684
- Licence
- CA C55215, HI MD-13862, RI MD11497California C55215: Current · expires 2027-10-31
- Group
- County of Santa Clara · Sanford Medical Center
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IA 0494724, RI 7057399
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 74-517 Honokohau St, Kailua Kona, HI, 96740
- NPI first listed
- 2005-11-10
- NPI last updated
- 2021-05-26
- NPI record certified
- 2021-05-26
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.